Results 141 to 150 of about 41,795 (272)
A novel kirkovirus may be associated with equine gastrointestinal disease
Equine Veterinary Journal, Volume 58, Issue 2, Page 414-422, March 2026.Abstract Background Many cases of equine enterocolitis are suspected to be infectious in nature, but no pathogen is identified in many cases. Objectives Perform next‐generation sequencing on faeces collected from cases of equine enterocolitis for the presence of novel viruses and determine if an identified novel virus is associated with cases of equine
Lillian M. B. Haywood +3 more
wiley +1 more source
Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma
Veterinary and Comparative Oncology, Volume 24, Issue 1, Page 51-57, March 2026.ABSTRACT Mechlorethamine is commonly prescribed to dogs at 3 mg/m2. The minimal toxicity observed indicates that higher doses of mechlorethamine are likely tolerable. The primary objective of this study was to determine the maximally tolerated dose (MTD) of mechlorethamine in dogs with lymphoma.
Laura E. Chadsey +2 more
wiley +1 more source
British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 535-544, February 2026.Introduction Bevacizumab, a vascular endothelial growth factor inhibitor, is used off‐label for treatment of severe anaemia related to epistaxis, gastrointestinal bleeding and/or severe hepatic arteriovenous malformations (HAVM) and right‐sided cardiac failure in patients with hereditary haemorrhagic telangiectasia (HHT).
Pernille D. Haahr +18 more
wiley +1 more source
Brain and Behavior, Volume 16, Issue 2, February 2026.This retrospective study showed that central nervous system (CNS) involvement in adult‐onset secondary hemophagocytic lymphohistiocytosis (sHLH) defines a severe phenotype and presented as an independent predictor of mortality. This study highlights the critical need for early neurological assessment and the development of CNS‐targeted treatment ...
Xue Wang +3 more
wiley +1 more source
Cancer Medicine, Volume 15, Issue 2, February 2026.ABSTRACT Introduction Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of non‐Hodgkin lymphoma, and despite advances in frontline therapies such as rituximab, cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), and prednisone, approximately 30%–40% of patients develop relapsed or refractory (
Dana Sofian Abou +6 more
wiley +1 more source
Thrombocytopenia and Bleeding in Patients With Oncologic Emergencies Following Cancer Therapy
Cancer Medicine, Volume 15, Issue 2, February 2026.ABSTRACT Objective There is a lack of studies investigating Cancer therapy‐induced thrombocytopenia (CTIT) and the risk factors predicting CTIT‐related hemorrhage in the emergency oncology patient population. This study aimed to present Chinese data on CTIT and organ bleeding in patients undergoing emergency oncology.
Le Tian +13 more
wiley +1 more source
What Is Your Diagnosis? Abnormal WDF Scattergram From the Sysmex XN‐1000V in a Cat
Veterinary Clinical Pathology, EarlyView.
Javier Martínez‐Caro +5 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 2, February 2026.ABSTRACT Acute acalculous cholecystitis can rarely be the initial manifestation of systemic lupus erythematosus. Awareness of this atypical presentation is essential to avoid unnecessary surgical intervention. Prompt recognition and initiation of immunosuppressive therapy may resolve symptoms and help establish the correct underlying diagnosis.
Mohammad Mehdi Shadravan +8 more
wiley +1 more source
Managing the Complex Intersection Between Substance Use Disorders and Infectious Diseases
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 3, March 2026.
Karissa Chow +4 more
wiley +1 more source